Home » Topics » Regulatory » Patents

Patents
RSS

Novel class of muscarinic receptor agonists described by Pfizer

Jan. 30, 1998

Prokinetic motilin agonists in development at Ohmeda

Jan. 30, 1998

Tsumura team reveals semisynthetic huperzine derivatives

Jan. 29, 1998

More new agents for influenza from Lilly

Jan. 29, 1998

Meiji Seika describes 5-HT3 partial agonists for GI disorders

Jan. 29, 1998

New excitatory amino acid antagonists in development at Pfizer

Jan. 29, 1998

Inhibitors of the production or release of sCD23, TNF

Jan. 29, 1998

Dopamine D4 receptor antagonists for imaging and therapy disclosed by Janssen

Jan. 29, 1998

BMS discloses new Taxol derivative

Jan. 28, 1998

Phenylglycine derivatives with mGluR-antagonist activity disclosed by Lilly

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...